SARS-CoV-2: lessons from both the history of medicine and from the biological behavior of other well-known viruses

Future Microbiol. 2021 Sep;16(14):1105-1133. doi: 10.2217/fmb-2021-0064. Epub 2021 Sep 1.

Abstract

SARS-CoV-2 is the etiological agent of the current pandemic worldwide and its associated disease COVID-19. In this review, we have analyzed SARS-CoV-2 characteristics and those ones of other well-known RNA viruses viz. HIV, HCV and Influenza viruses, collecting their historical data, clinical manifestations and pathogenetic mechanisms. The aim of the work is obtaining useful insights and lessons for a better understanding of SARS-CoV-2. These pathogens present a distinct mode of transmission, as SARS-CoV-2 and Influenza viruses are airborne, whereas HIV and HCV are bloodborne. However, these viruses exhibit some potential similar clinical manifestations and pathogenetic mechanisms and their understanding may contribute to establishing preventive measures and new therapies against SARS-CoV-2.

Keywords: COVID-19; SARS-CoV-2 pandemic; infectious diseases; pathogenesis; treatment.

Publication types

  • Historical Article
  • Review

MeSH terms

  • Antiviral Agents / therapeutic use
  • COVID-19 / epidemiology
  • COVID-19 / history*
  • COVID-19 / transmission
  • COVID-19 Drug Treatment
  • Climate
  • Disease Reservoirs / virology
  • Genome, Viral
  • History, 19th Century
  • History, 20th Century
  • History, 21st Century
  • Humans
  • Mutation
  • Pandemics / history*
  • RNA Viruses / pathogenicity
  • RNA Viruses / physiology
  • Reinfection / epidemiology
  • Reinfection / history
  • Reinfection / transmission
  • Reinfection / virology
  • Respiratory Tract Infections / drug therapy
  • Respiratory Tract Infections / epidemiology
  • Respiratory Tract Infections / history
  • Respiratory Tract Infections / transmission
  • SARS-CoV-2 / pathogenicity*
  • SARS-CoV-2 / physiology*
  • Virus Replication

Substances

  • Antiviral Agents